Guidelines for the Pharmacologic Treatment of COPD 2023: Canada versus GOLD
Saved in:
| Main Author: | Samy Suissa |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | COPD |
| Online Access: | https://www.tandfonline.com/doi/10.1080/15412555.2023.2292613 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacologic Treatment of COPD: Disparities Between Evidence and Recommendations in GOLD 2023/4
by: Samy Suissa
Published: (2025-12-01) -
Triple Inhaler versus Dual Bronchodilator Therapy in COPD: Real-World Effectiveness on Mortality
by: Samy Suissa, et al.
Published: (2022-12-01) -
Prompt versus Delayed Triple Therapy in COPD: Solutions to Time-Related Biases in Observational Studies
by: Suissa S, et al.
Published: (2025-07-01) -
Effectiveness of Aspirin on Major COPD Outcomes: A Prevalent New-User Design Observational Study
by: Charles Khouri, et al.
Published: (2024-12-01) -
The Good COPD Guidelines
by: Dennis Bowie
Published: (2004-01-01)